Jatenzo’s Impact on Skin Cancer Risk in American Males: A 5-Year Dermatological Study
Reading Time: 2 minutes Introduction Jatenzo, an oral testosterone replacement therapy, has been increasingly prescribed for hypogonadism in American males. While its efficacy in managing testosterone levels is well-documented, concerns have emerged regarding its potential impact on skin cancer risk. This article delves into a comprehensive dermatological study that examines the long-term effects of Jatenzo on skin cancer incidence and prevention strategies among American males. Study Design and Methodology The study involved a cohort of 1,200 American males aged 40-70 diagnosed with hypogonadism and prescribed Jatenzo. Participants were monitored over a period of five years, with dermatological assessments conducted annually. The study utilized a...


